Objective-To determine the role of orai1 store-operated Ca 2+ entry in foam cell formation and atherogenesis. Approach and Results-Acute administration of oxidized low-density lipoprotein (oxLDL) activates an orai1-dependent Ca 2+ entry in macrophages. Chelation of intracellular Ca
T he formation and development of atherosclerotic lesions is a chronic inflammatory process involving complex interactions of modified lipoproteins, monocytes, and T lymphocytes with cellular components in the vessel wall. [1] [2] [3] [4] During atherogenesis, inflammatory response would induce the transmigration of circulating monocytes into the subintima to become macrophages, where these macrophages transform into foam cells when exposure to modified lipoproteins such as the oxidized and acetylated forms of low-density lipoproteins (oxLDL and acLDL) through macrophage scavenger receptors (SRs), including SR-A and CD36. [3] [4] [5] [6] [7] Although the formation of foam cells in the arterial wall has long been recognized as a critical step in the development of atherosclerosis, 3, 7, 8 the mechanisms whereby oxLDL initiates this process are not well understood. Ca 2+ is an ubiquitous second messenger, which is involved in regulation of a variety of cellular functions. 9, 10 Previous studies have observed that intracellular Ca 2+ concentration ([Ca 2+ ] i ) is increased in atherosclerotic vascular smooth muscle cells. 11 Despite increasing evidence supporting that the rise of intracellular Ca 2+ is involved in several important atherogenesis-associated processes such as abnormal contraction and proliferation of vascular smooth muscle cells, excessive secretion of extracellular matrix proteins, overproduction of chemoattractants and growth factors, and platelet aggregation, 12 the direct role of Ca 2+ in foam cell formation did not attract enough attention.
Recently, several works have shown that acute administration of oxLDL could elicit a significant increase of [Ca 2+ ] i in different cell types, including vascular smooth muscle cells, endothelial cells, and macrophages. [13] [14] [15] This increase of [Ca 2+ ] i is dependent on intracellular Ca 2+ store and inositol trisphosphate production because preincubation of thapsigargin, an inhibitor of endoplasmic reticulum Ca 2+ -ATPase, abolished oxLDL-induced rise of [Ca 2+ ] i . 14, 15 However, which Ca 2+ channel underlying oxLDL-induced Ca 2+ entry has not been determined. Store-operated Ca 2+ (SOC) channel is the major route for Ca 2+ entry in nonexcitable cells. 16, 17 Under physiological status, SOC channel is activated by triphosphate (inositol trisphosphate)-mediated depletion of endoplasmic reticulum Ca 2+ in response to the activation of phospholipase C-coupled receptors. Recent studies have identified 2 molecules, stromal interaction molecule 1 (Stim1) and orai1 (also called CRACM1), are responsible for SOC entry. [18] [19] [20] [21] [22] [23] Stim1 resides in endoplasmic reticulum and serves as a Ca 2+ sensor, whereas orai1 mainly locates at plasma membrane and functions as a pore-forming component of SOC channel. 19, 23 Accumulating evidence has demonstrated that orai1 Ca 2+ channel plays a critical role in regulating T-and B-cell function, 24, 25 endothelial and vascular smooth muscle cell proliferation, [26] [27] [28] [29] neutrophil migration, 30 and injury-induced neointima formation. 31 Although the disturbance of these processes have been suggested to be critical for atherogenesis, the functional role of orai-dependent Ca 2+ entry in atherosclerosis formation remains enigmatic.
Interestingly, Stim1 and orai1, as well as their homologues Stim2 and Orai 2, Orai3, have been found to be abundantly expressed in human macrophage and the SOC entry in macrophage is mediated primarily by Sim1 and Orai1. 32 Therefore, the aim of this study is to investigate the hypothesis that orai1 mediates oxLDL-activated [Ca 2+ ] i increase in macrophage and activation of Orai1 Ca 2+ channel contributes to foam cell formation and atherogenesis.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Orai1 Is Required for oxLDL-Induced Ca 2+ Influx in Macrophages
OxLDL (50 µg/mL) activates a biphasic increase of [Ca 2+ ] i in THP-1-derived macrophages and mouse peritoneal macrophages (Figure 1 ; Figure I in the online-only Data Supplement). Both 2-aminoethoxydiphenylborane (2-APB, an inositol trisphosphate receptor antagonist, 100 µmol/L) and SKF96365 (a SOC channel blocker, 20 µmol/L) remarkably inhibited oxLDL-induced [Ca 2+ ] i increase, but verapamil (a L-type voltage-dependent Ca 2+ channel blocker, 20 µmol/L) had no effect ( Figure 1A ; Figure To investigate whether defective binding or uptake of modified lipoproteins accounts for impaired foam cell formation after inhibition of orai1 Ca 2+ channel. We assessed receptormediated binding and uptake of fluorescently labeled oxLDL (Dil-labeled oxLDL). Our results revealed that binding and uptake of Dil-labeled oxLDL in macrophages treated with BAPTA/AM, 2-APB or SKF96365 were markedly decreased ( Figure 1G , 1H, 1J, and 1K; Figure IIIA , IIIB, IIID, and IIIE in the online-only Data Supplement). Moreover, we found that the binding and uptake of Dil-labeled oxLDL in orai1 siRNAtreated macrophages were about one third of that in control siRNA-treated cells (Figure 1I and 1L ; Figure IIIC and IIIF in the online-only Data Supplement). 
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Inhibition of Orai1 Ca 2+ Influx Decreases SR-A Expression
To explore the molecular mechanisms by which orai1 inhibition blunted binding and uptake of DiI-oxLDL, the expression of SRs, SR-A and CD36, were determined. Knockdown of orai1 nearly abrogated oxLDL-induced upregulation of SR-A mRNA and protein levels (Figure 2A and 2B) . In contrast to SR-A, orai1 siRNA transfection did not affect CD36 expression ( Figure IV4A and IVB in the online-only Data Supplement). The similar effects of orai1 knockdown on SR-A and CD36 expression were also observed in mouse peritoneal macrophages ( Figure IV4C increase (n=8 in each group). B, Western blotting showed that orai1 siRNA transfection for 48 hours decreased orai1 protein expression in THP-1-derived macrophages. *P<0.05, **P<0.01 vs scramble siRNA (scr. RNA); n=6. C, orai1 deficiency reduced oxLDL-induced intracellular Ca 2+ increase n=6. D-F, THP-1 macrophages were treated with BAPTA-AM (10 µmol/L) (D), 2-APB (50 µmol/L), SKF96365 (20 µmol/L), or verapamil (20 µmol/L, E) for 3 hours, or treated with orai1 siRNA (F) for 48 hours. Then oxLDL (50 µg/mL) was added into the culture medium for another 24 hours. Cells were then collected to measure cholesterol content. **P<0.01 vs control, #P<0.05, ##P<0.01 vs oxLDL+dimethyl sulphoxide (DMSO), n=5. G-L, THP-1 macrophages were treated with BAPTA-AM (G and J), 2-APB, SKF96365, or verapamil (H and K), or orai1 siRNA (I and L) before oxLDL incubation. Then the cells were exposed to DiI-labeled oxLDL for 2 hours at 4°C or for 4 hours at 37°C to assess binding (G-I) or uptake (J-L) of Dil-labeled oxLDL, respectively. **P<0.01 vs control, #P<0.05, ##P<0.01 vs oxLDL+DMSO, n=6 to 8. ] i increase. 10 To identify which pathway is involved in orai1-mediated upregulation of SR-A, we investigated the effects of pharmacological inhibition of Ca 
Calcineurin-Dependent but NFAT-Independent Pathway Contributes to Foam Cell Formation
ASK1-JNK/p38 MAPK Signaling Links Calcineurin to SR-A Upregulation and Foam Cell Formation
Previous studies have demonstrated that mitogen-activated protein kinases (MAPKs), in particular JNK and p38 MAPK, play an important role in regulation of SR-A expression. 33 In fact, oxLDL treatment increased the phosphorylation of both Apoptosis signal-regulating kinase 1 (ASK1) is an MAPK kinase kinase, which serves as the upstream regulator of JNK and p38 MAPK activity. 34 Of note, calcineurin has been found to directly interact with ASK1 in cardiomyocytes, which induces dephosphorylation of ASK1 and increases its activity. 35 So we then tested whether ASK1 couples Ca 
Inhibition of Orai1 Ca
2+ Influx Impairs Binding Capacity of SR-A Next, we examined whether orai1 Ca 2+ influx affects the binding capacity of SR-A in macrophages. The concentrationdependent binding curves showed that oxLDL increased the affinity of oxLDL with SR-A ( Figure 4A ). oxLDL treatment decreased the Kd value and increased the maximal binding capacity. SKF96365 or orai1 siRNA dramatically reversed the effects of oxLDL on the affinity of SR-A ( Figure 4A ; Table) . Serine phosphorylation of SR-A has been proposed to be essential in regulating the binding capacity of SR-A. 33 Indeed, oxLDL-activated serine phosphorylation of SR-A in a timedependent manner, which peaked at 1 minute ( Figure 4B ). Inhibition of orai1 Ca 2+ channel with 2-APB, SKF96365, or orai1 siRNA significantly blunted SR-A phosphorylation ( Figure 4C and 4D ). These data indicated that decrease of SR-A serine phosphorylation also contributes to the reduced foam cell formation after blockade of orai1 Ca 2+ entry.
Inhibition of Orai1 Ca 2+ Channel Restricts Atherosclerosis Development in ApoE −/− Mice
Foam cell formation is a key step during atherogenesis, so we investigated the effect of orai1 knockdown on atheroma formation in vivo. Eight-week-old apolipoprotein E (apoE −/− ) mice were fed with high-fat diet (HFD) for 8 weeks, and then Ad-Orai1 siRNA or Ad-GFP siRNA was introduced for 4 weeks ( Figure IX in the online-only Data Supplement). After 12 weeks on HFD, orai1 expression in the aorta was increased ( Figure 5A and 5B), which was remarkably inhibited after Ad-Orai1 siRNA administration ( Figure 5C and 5D). Simultaneously, SR-A expression in the lesions was also decreased after Ad-Orai1 siRNA treatment ( Figure 5E ). In Ad-Orai1 siRNA-treated group, the aortic atherosclerotic plaque area was significantly decreased (11.1±3.6% versus 24.2±4.3%, P<0.01, n=10; Figure 5F and 5G). Compared with Ad-GFP siRNA-treated mice, the atherosclerotic plaque size in the aortic arch was also dramatically alleviated in Ad-Orai1 siRNA-treated group (0.28±0.05 mm 2 versus 0.45±0.09 mm 2 , P<0.01, n=10; Figure 5H and 5I).
To further explore the potential therapeutic effect of orai1 Ca 2+ channel inhibition on atherosclerosis formation, we treated apoE −/− mice with SKF96365 (10 mg/kg pet day) or vehicle for the last 4 weeks of a total of 12 weeks of an HFD. SKF96365 treatment reduced SR-A expression in the plaque ( Figure 5E ) and caused ≈50% reduction of atherosclerotic plaque formation both in the entire aorta and the aortic arch compared with mice treated with vehicle ( Figure 5F-5I) . 
Blockade of Orai1 Ca 2+ Channel Inhibits Macrophage Apoptosis
Proliferation and apoptosis of macrophage play an essential role in atherosclerosis development. To investigate the effect of orai1 on macrophage survival, THP-1 cells pretreated with orai1 siRNA or SKF96365 were exposed to oxLDL. As shown in Figure 6 , oxLDL incubation decreased cell viability and increased cell apoptosis. Orai1 siRNA transfection or SKF96365 treatment blocked oxLDL-induced mitochondria cytochrome c release and caspase 3 cleavage, and thus inhibited macrophage apoptosis. Consistently, TUNNEL (transferasemediated deoxyuridine triphosphate-biotin nick end labeling)-positive area in the lesions after orai1 siRNA or SKF96365 administration was less than that in corresponding control group ( Figure 6D ). These observations indicated that orai1 Ca 2+ channel plays an important role in macrophage apoptotic pathway.
Inhibition of Orai1 Ca 2+ Channel Alleviates Vessel Inflammation and Myeloid Cell Recruitment
Lesional macrophages can secrete abundant amounts of cytokines and chemokines, which further promotes the recruitment of other immune cells into the vessel wall and the development of atherosclerosis. Indeed, the number of CD68-positive macrophages, Ly-6G-positive neutrophils, and CD3-positive T cells was remarkably increased in aortic arch lesions of apoE −/− mice after 3 months of HFD feeding. Inhibition of orai1 Ca 2+ entry and knockdown of orai1 significantly decreased the infiltration of these myeloid cells into the vessel wall during atherogenesis ( Figure 7A-7C ). In addition, we also observed both orai1 siRNA and SKF96365 treatment reduced the expression of tumor necrosis factor-α, interleukin (IL)-1β, IL-6, and CXCL2 in aorta of apoE −/− mice after 3 months on an HFD ( Figure 7D ).
Discussion
The breakthrough in the past several years about SOC entry is the identification of Orai1 and Stim1, as well as their homologous Orai2, Orai3, and Stim2, as the critical components of SOC channel. [19] [20] [21] [22] [23] 36, 37 On the basis of these observations, recent studies revealed that SOC entry plays an important role in diverse cellular processes, such as immunologic response, cell proliferation, and migration. [24] [25] [26] [29] [30] [31] [37] [38] [39] In this study, we provided the evidence that orai1-mediated Ca 2+ entry is an essential contributor to atherogenesis because both knockdown of orai1 expression and pharmacological inhibition of SOC channel in vivo significantly decreased atherosclerotic plaque formation in apoE −/− mice. Accumulation of lipid-laden foam cells in the arterial intima is a hallmark and early key step for atherogenesis. Modified LDLs, such as oxLDL, have been recognized to be causative contributors to the foam cell formation and atherosclerotic lesion progression. 2, 3, 8 Previous studies have shown that acute treatment of oxLDL can trigger an immediate rise of [Ca 2+ ] i in macrophages and vascular smooth muscle cells. and this oxLDL-activated Ca 2+ increase is dependent on Ca 2+ store. [13] [14] [15] Consistent with these reports, we also observed a Ca 2+ store-dependent Ca 2+ increase in human and murine macrophages after oxLDL administration. Knockdown of orai1 remarkably inhibited oxLDL-stimulated Ca 2+ increase, indicating that orai1 is the major route for oxLDL-induced Ca 2+ entry in macrophages. Moreover, we found that chelation of intracellular Ca 2+ , pharmacological inhibition of SOC entry with 2-APB and SKF96365, or silencing of orai1 by siRNA transfection all dramatically reduced the binding and uptake of modified LDL and inhibited oxLDL-induced cholesterol accumulation in macrophages, indicating that orai1-mediated Ca 2+ entry plays a crucial role in foam cell formation.
Macrophage SRs, including CD36 and SR-A, have been demonstrated to play a critical role in foam cell formation by recognition and internalization of modified LDL. On the basis of the observations, calcineurin but not Ca 2+ /calmodulin-dependent kinase II is required for oxLDLinduced SR-A upregulation and foam cell formation. We investigated whether activation of NFAT transcription factors, the well defined downstream effectors of calcineurin, 40 links calcineurin activation to SR-A upregulation. Unexpectedly, although 4 calcineurin-regulated NFAT transcription factors (NFAT1-4) are expressed in macrophages, knockdown of NFAT4, the most abundant subtype in macrophages, did not inhibit, but rather increased, oxLDL-induced SR-A expression. These findings suggest NFAT transcription factors are negative regulators of SR-A expression and the other signaling pathway rather than NFAT is involved in calcineurin-activated SR-A upregulation. Interestingly, recent studies have demonstrated that the activity of ASK1, an MAPK kinase kinase which mediates the activation of the MKK3/6-p38 and MKK4/7-JNK signaling cascades, 34, 40 is positively regulated by calcineurin via direct interaction. 35 Here, we found that knockdown of orai1 prevented oxLDL-stimulated activation of ASK1 and its downstream effectors p38 and JNK. Moreover, knockdown of ASK1 or inhibition of p38 and JNK dramatically blunted oxLDL-induced upregulation of SR-A and foam cell formation. The data suggested ASK1-p38/JNK is the molecular link between calcineurin activation and SR-A expression. However, ASK1 has no effect on ABCA1 expression ( Figure VIC in the online-only Data Supplement), indicating this signaling pathway is not involved in the removal of cholesterol from foam cells.
Collectively, our findings showed that orai1-triggered increase of intracellular Ca 2+ activates calcineurin, which in turn activates 2 signaling cascades. Calcineurin-ASK1-p38/ JNK signaling pathway positively regulates SR-A expression and promotes foam cell formation. In contrast, calcineurin-NFAT pathway negatively modulates SR-A expression. Interestingly enough, recent studies have revealed that p38 and JNK function as NFAT kinases and counteract calcineurinactivated NFAT translocation to nucleus. 35, 41 Therefore, we can infer that the upregulation of SR-A after orai1 channel activation arises from the integrated effects of these 2 signaling pathways. ASK1 activation limits the inhibitory effect of NFAT on SR-A expression through this negative feedback mechanism.
A large amount of evidence has accumulated that inflammation and activation of immune cells are crucial mechanisms for initiation and progression of atherosclerosis.
1,2 Stim1-and orai1-mediated SOC entry has recently been suggested to play an essential role in regulating lymphocyte activation and neutrophil migration. 24, 30 The absence of Stim1 or Orai1 compromises the functions of T cells, B cells, and mast cells. 24 Moreover, several reports also showed that orai1-mediated Ca 2+ entry regulates NF-B activation and cytokine production in air epithelial cells and lung cancer cells. 42, 43 Here, we found that inhibition of orai1 signaling reduced several inflammatory genes expression both in cultured macrophages and in atherosclerotic lesions. In addition, recruitment of immune cells, including macrophages, T lymphocytes and neutrophils, into lesional vessels was decreased after blockade of orai1 signaling. The reduced accumulation of these immune cells in the vessel wall may not be related to increased cell death because inhibition of orai1 channel prevented macrophage apoptosis. Considering that deficiency of orai1 could delay the onset of neutrophil arrest and polarization, 30 we inferred that the impaired migratory function might contribute to the reduction of immune cell infiltration during atheroma.
In summary, our present results unmasked the critical role of orai1 Ca 2+ entry in the development of atherogenesis. Blockade of orai1 signaling impairs foam cell formation, reduces vascular inflammation and alleviates immune cell infiltration, and thus prevents atherosclerotic lesion progression. Our data suggest orai1 Ca 2+ channel may be a potential therapeutic target for atherosclerosis. Foam cell formation and inflammation play a critical role in the development of atherosclerotic lesions. Increase of intracellular Ca 2+ has been suggested to be involved in several important atherogenesis-associated processes. In this study, we found that acute administration of oxidized low-density lipoprotein activates an orai1-dependent Ca 2+ entry in macrophages. Blockade of orai1 Ca 2+ channel dramatically attenuated oxidized low-density lipoprotein-induced scavenger receptor A (SR-A) expression, lipid uptake and foam cell formation. Orai1-dependent Ca 2+ entry induces SR-A expression and foam cell formation through activation of calcineurin but not calmodulin kinase II. Moreover, inhibition of orai1 channel prevents oxidized low-density lipoprotein-induced apoptosis signal-regulating kinase 1 activation. Knockdown of apoptosis signal-regulating kinase 1 reduces SR-A expression and foam cell formation. Furthermore, blockade of orai1 channel restricts atherosclerotic plaque formation in apolipoprotein E −/− mice. These findings indicate that orai1-dependent Ca 2+ entry plays a critical role in foam cell formation and atherogenesis, suggesting orai1 Ca 2+ channel is a potential novel therapeutic target for atherosclerosis.
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